# An Evaluation of the Safety and Efficacy of Memantine in Patients With Acute Mania Associated With Bipolar I Disorder

> **NCT00106405** · PHASE2 · COMPLETED · sponsor: **Forest Laboratories** · enrollment: 35 (actual)

## Conditions studied

- Bipolar Disorder

## Interventions

- **DRUG:** Memantine HCl

## Key facts

- **NCT ID:** NCT00106405
- **Lead sponsor:** Forest Laboratories
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-02
- **Primary completion:** 2005-11
- **Final completion:** 2005-11
- **Target enrollment:** 35 (ACTUAL)
- **Last updated:** 2012-03-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00106405

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00106405, "An Evaluation of the Safety and Efficacy of Memantine in Patients With Acute Mania Associated With Bipolar I Disorder". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT00106405. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*